Trial watch: dendritic cell vaccination for cancer immunotherapy
/in Dendritic Cells, International Publications /von 2019-07-18 / Oncoimmunology 2019;8(11):e1638212Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
/in Curcuma, International Publications /von 2019-07-12 / Pharmacol Res 2019 09;147:104353Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review
/in Breast Cancer, International Publications, Micronutrients /von 2019-07-01 / In Vivo 2019 Jul-Aug;33(4):983-997
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution